GRFS - CIK 0001438569
Grifols SA trades as GRFS and has a market capitalization of $6.77 B, making it the #1175 largest US-listed company by market value. This page tracks Grifols SA through 457 SEC filings, with financial statements and metrics updated as new reports are filed.
| Filing | Type | Filed |
|---|---|---|
| 6-K | - | 2026-05-15 |
| SCHEDULE 13G/A | - | 2026-05-14 |
| 6-K | - | 2026-05-07 |
| 20-F | - | 2026-04-17 |
| 6-K | - | 2026-04-14 |
| 6-K | - | 2026-03-24 |
| 6-K | - | 2026-02-26 |
| 6-K | - | 2026-02-26 |
Annual General Shareholders’ Meeting 2026 – Expected to be held on: June 18, 2026 - 2nd call / June 17, 2026 - 1st call
Grifols increases Q1 2026 revenues by 3.3% to €1.7billion, and net profit 21.9% to €73 million · Q1 2026 performance was aligned with plan and on ...
The largest companies sharing Grifols SA's SEC industry classification (pharmaceutical preparations).
Grifols SA (GRFS) has a market capitalization of $6.77 B as of 2026-05-29, ranking #1175 among US-listed companies.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.